Wieslawa Niklinska Selected Research

Lung Neoplasms (Lung Cancer)

1/2009	Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC).
1/2007	DNA methylation in states of cell physiology and pathology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wieslawa Niklinska Research Topics

Disease

7	Neoplasms (Cancer) 09/2022 - 01/2007
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2017 - 01/2008
2	Carcinoma (Carcinomatosis) 02/2016 - 01/2007
2	Lung Neoplasms (Lung Cancer) 01/2009 - 01/2007
1	Adenocarcinoma of Lung 02/2016
1	Endometrial Neoplasms (Endometrial Cancer) 08/2010
1	Adenocarcinoma 01/2008
1	Neoplasm Metastasis (Metastasis) 01/2007
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2007
1	Mesothelioma 08/2004

Drug/Important Bio-Agent (IBA)

2	LigandsIBA 09/2022 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 02/2016 - 01/2007
2	DNA (Deoxyribonucleic Acid)IBA 08/2010 - 01/2009
1	Monoclonal AntibodiesIBA 09/2022
1	delta proteinIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 02/2016
1	Cell-Free Nucleic AcidsIBA 08/2010
1	Death-Associated Protein KinasesIBA 01/2009
1	Proteins (Proteins, Gene)FDA Link 01/2008
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2008
1	Fas Ligand Protein (Fas Ligand)IBA 01/2007
1	vasectrin IIIIBA 01/2007
1	AsbestosIBA 08/2004

Therapy/Procedure

3	Therapeutics 09/2022 - 02/2016
1	Immunotherapy 09/2022